Expertly delivering clinical trials, to people at home, in places all over the world
The ability to reach diverse patient populations and reduce the burden for people taking part in a clinical trial is imperative. Our Almac to Patient solution has been developed with a patient-centric approach, enabling sponsors to include patient homes as part of their decentralised trial strategy.
We understand that patient recruitment and retention is one of the biggest challenges to the success of clinical trials. Our supply chain experts, global quality, and clinical supply infrastructure, ensures effective, convenient and personalised delivery of IMP to the front doors of patients’ homes.
We achieve this via an Almac to Patient or Site to Patient solution, depending on country requirements and protocol need; providing a controlled, complete, and care-focused approach that keeps patients at the heart of the operation, every step of the journey home.
End-to-end control
Almac to Patient provides end-to-end control with bespoke supply chain design; expert guidance on drug forecasting, inventory strategy, and IRT set-up; GDPR and HIPAA compliant software underpinned by our global quality framework; encrypted PII and study blinding processes; and visualisation of the entire process, as part of the overall clinical trial.
The complete package
We have experience across all phases and therapeutic areas, and the flexibility to meet protocol and country-specific needs. With Almac to Patient, expect secure, GDP courier management pathways for ambient and temperature-controlled IMP; security of delivery to patients’ homes; supporting pharmacy services; and returns management. Everything you need from one, expert partner.
A better patient experience
Almac to Patient is care-focused by design; providing simplified, accurate and controlled processes that help reduce patient and site burden. In doing so, our managed and dedicated service and expert people facilitate the inclusion of more diverse patient populations and a better experience.
The Almac to Patient solution
